Active, not recruitingNCT07511517

BladMetrix Urine Test for Monitoring Recurrence in Non-Muscle Invasive Bladder Cancer

Studying Muscular tumor

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Oslo University Hospital
Principal Investigator
Rolf Wahlqvist, MD, PhD
Oslo University Hospital - Aker
Intervention
BladMetrix urine test(diagnostic_test)
Enrollment
500 enrolled
Eligibility
18 years · All sexes
Timeline
2019 – 2027

Study locations (6)

Collaborators

Oslo University Hospital - Aker · University Hospital, Akershus · Haukeland University Hospital · St. Olavs Hospital · Vestfold Hospital Trust (SiV) · University Hospital of North Norway · Clinical Therapy Research in the specialist health services · The Research Council of Norway · CellCap Solutions ApS - provides the filtration device used for urine sample collection and subsequent storage in this study · South-Eastern Norway Regional Health Authority

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT07511517 on ClinicalTrials.gov

Other trials for Muscular tumor

Additional recruiting or active studies for the same condition.

See all trials for Muscular tumor →

← Back to all trials